Delve Health
Case Studies
Clinical StudyPal
Medical Device Company Monitoring Patients with Heart Disease
Solutions Used: Apple Watch Series 6, Clinical StudyPal ePRO and eConsent
Client was interested in patient concierge services to purchase and configure all the smart watches, as well as simplify the solution to remotely monitor patient heart rates and motion activities.
Delve Health uploaded Clinical StudyPal app onto 200 Apple watches and deployed the wearable devices to participating patients across the US.
Investigative sites utilized Delve Health’s eConsent solution to remotely eConsent patients into the study.
Patients wore the Apple watches for a period of one (1) year and received ePRO questions via the wearable device.
Client used Delve Health’s data collection solution to analyze the patient data from the Apple watch and ePROs.
Pharma Company Oncology Clinical Trial
Solutions Used: Randomization, eConsent and ePRO
Client was interested in integrating simplified workflow solutions to quickly randomize, eConsent and collect patient reported outcomes remotely from patients.
Delve Health configured their IWRS solution; uploaded all patient eConsent multi-media information; as well as setup ePRO for patients in multiple, international locations.
Investigators randomized patients into Clinical StudyPal. After randomization, patients received an SMS message to download the app and eConsent into the study.
Patients had the option to login to Clinical StudyPal on a computer or download a smartphone app (iOS or Android) to eConsent and respond to their eDiaries. Patients were notified of their eDiary requirements and activities via SMS.
Client utilized Clinical StudyPal to remotely monitor patient progress and manage their compliance.
Medical Device Company Monitor Hypertension
Solutions Used: Blood Pressure Device, Clinical StudyPal ePRO and eConsent
Client was interested in a solution to remotely monitor patients’ hypertension at home.
Delve Health integrated our technology solution with the blood pressure monitor and managed the activation of the blood pressure monitors across the US and EU. We also utilized our ePRO solution to collect patient reported outcomes via their smart phones.
Patients received SMS or WhatsApp messages for ePRO notifications, based on their geographical locations.
Delve Health collected and analyzed patient data from the blood pressure monitors.
Client utilized Delve Health’s technology solutions to collect and analyze patient outcomes.
Pharma Company Diabetic Patients
Solutions Used: Clinical StudyPal ePRO, eConsent and Video Visits
Client was interested in monitoring the dietary habits of patients with diabetes. Utilizing a diet app to remotely monitor patient food intake and their time of medication.
Delve Health configured the diet app, integrating our ePRO solution, to allow patients to log their breakfast, lunch, snacks and dinner; as well as allow entries of the times of medication intake.
Patients interacted with the seamless app to enter their meals and their medication times.
Delve Health configured a select set of reports to remotely monitor patient logs and ePROs to ensure and “nudge” compliance.
Client utilized Clinical StudyPal to remotely monitor patient compliance and create queries for sites.
Concierge Services
Reducing Screen Failures by 40% Using Secondary Screening Automation
Sponsor: Mid-size biotech company
Study Type: Phase II oncology trial
Challenge:
The sponsor experienced a 60% screen failure rate after initial referrals. Patients were enrolling based on basic eligibility but failing later due to comorbidities or lab criteria.
Delve Health Solution:
Implemented a configurable secondary screening workflow that layered in detailed pre-screen questions based on I/E criteria
Integrated wearable and EHR data for early rule-out
Automated logic branching allowed sites to focus only on viable candidates
Results:
- Screen failure dropped from 60% to 36%
- Site burden reduced by 50% (less manual review)
- Enrollment timelines improved by 3 weeks
- Improved patient experience with faster “yes/no” pathway
Using Digital Secondary Screening to Identify Hard-to-Find Patients for a Rare Disease Trial
Sponsor: Global pharmaceutical company
Study Type: Rare disease, observational registry
Challenge:
The sponsor needed to pre-qualify patients across 7 countries with very specific phenotypic and symptom patterns — most of whom had not yet been formally diagnosed.
Delve Health Solution:
- Designed a multilingual digital pre-screener tailored to symptom patterns and risk factors
- Used logic-based routing and remote review to escalate only highly matched profiles
- Included optional wearable triggers (e.g., activity levels, sleep disruptions)
Results:
- Identified 73 high-likelihood patients across 6 countries within 45 days
- Increased enrollment conversion by 2.3x compared to original referral sources
- Helped sites prioritize outreach and reduce outreach fatigue
Boosting Patient Confidence and Compliance Through Transparent Pre-Qualification
Sponsor: Medtech company
Study Type: Device study for hypertension management
Challenge:
Patients were dropping off between pre-screen and consent due to confusion about eligibility and study expectations.
Delve Health Solution:
- Implemented a mobile-based pre-screener that included educational videos, dynamic eligibility questions, and personalized guidance
- Used secondary screening to flag patients who might benefit from concierge support for follow-up
- Automated reminders + warm handoffs to sites
Results:
- 30% reduction in patient drop-off between pre-screen and consent
- Improved patient confidence, with 88% reporting they “understood the study better” after Delve’s flow
- Enabled targeted outreach from site coordinators, saving hours per patient
Finding Rare Disease Patients Through EMR Retrieval and Secondary Screening
Sponsor: Top 20 Pharmaceutical Company
Study Type: Phase III, U.S.-based rare disease study
Challenge:
The sponsor faced significant delays enrolling patients with a rare genetic condition.
Despite strong site relationships, recruitment was slow and fragmented — patients were being referred, but site teams were overwhelmed by the effort required to follow up, manage consent, retrieve records, and verify eligibility. Screen failure rates were high, and manual bottlenecks at every step of the process threatened the study timeline.
Delve Health Solution:
Delve Health deployed a centralized, tech-enabled patient screening and EMR access model that bridged the operational gap between site referral and enrollment:
- Participating sites referred potential patients based on preliminary fit
- Delve’s team contacted patients directly, obtained digital consent, and secured authorization for medical record retrieval
- Leveraged Delve’s proprietary system to retrieve and review patient EMRs for detailed inclusion/exclusion confirmation
- When automated EMR access was unavailable, Delve activated manual retrieval workflows with HIPAA-compliant processes
- Conducted secondary screening based on protocol criteria and coordinated eligible patients back to sites for enrollment
Results:
- Screened and reviewed 500+ patient records across participating U.S. sites
- Increased Phase III enrollment by 6x over 12 months
- Reduced screen failure by more than 50%
- Offloaded 60–70% of recruitment and screening burden from site staff
- Accelerated identification-to-enrollment timelines by centralizing consent, record access, and protocol pre-qualification
